The combination of NK41 with NK46 additively alleviated cognitive decline, neuroinflammation, and colitis by up-regulation of BDNF signaling and down-regulation of NF-κB signaling and gut microbiota dysbiosis. The gene discussed is BDNF; the disease is colitis.